BACKGROUND: In recent years, interest has been revived in the possibility of transplanting organs into humans from a phylogenetically disparate species such as the pig (xenotransplantation). Such discordant xenografts, however, are subject to hyperacute rejection (HAR) and activation of host complement plays a major role in this rejection. This problem may be solved through the use of transgenic technology by providing the grafted tissue with molecules that down-regulate the action of host complement. RESULTS: Transgenesis with a yeast artificial chromosome (YAC) was used to produce transgenic mice with the complete genomic gene of the human complement regulator membrane cofactor protein (MCP). Transgenic mice were obtained that exhibit full regulation of MCP as normally observed in humans. Hearts from these mice were shown to be significantly protected from HAR caused by human serum in an in vivo experimental procedure. CONCLUSIONS: We conclude that MCP can protect discordant xenografts from HAR caused by human serum and that transgenic mice can be used effectively as in vivo models for the study of the role of human complement regulatory molecules in xenotransplantation.

This article has been cited by other articles:

				S. Verhaagh, E. de Jong, J. Goudsmit, S. Lecollinet, G. Gillissen, M. de Vries, K. van Leuven, I. Que, K. Ouwehand, R. Mintardjo, et al. Human CD46-transgenic mice in studies involving replication-incompetent adenoviral type 35 vectors J. Gen. Virol., February 1, 2006; 87(2): 255 - 265. [Abstract] [Full Text] [PDF]

				O. J. A. E. Ophorst, K. Radosevic, M. J. E. Havenga, M. G. Pau, L. Holterman, B. Berkhout, J. Goudsmit, and M. Tsuji Immunogenicity and Protection of a Recombinant Human Adenovirus Serotype 35-Based Malaria Vaccine against Plasmodium yoelii in Mice Infect. Immun., January 1, 2006; 74(1): 313 - 320. [Abstract] [Full Text] [PDF]

				B. Hahm, N. Arbour, D. Naniche, D. Homann, M. Manchester, and M. B. A. Oldstone Measles Virus Infects and Suppresses Proliferation of T Lymphocytes from Transgenic Mice Bearing Human Signaling Lymphocytic Activation Molecule J. Virol., March 15, 2003; 77(6): 3505 - 3515. [Abstract] [Full Text] [PDF]

				N. Yannoutsos, P. Wilson, W. Yu, H. T. Chen, A. Nussenzweig, H. Petrie, and M. C. Nussenzweig The Role of Recombination Activating Gene (RAG) Reinduction in Thymocyte Development In Vivo J. Exp. Med., August 20, 2001; 194(4): 471 - 480. [Abstract] [Full Text] [PDF]

				B. Roscic-Mrkic, R. A. Schwendener, B. Odermatt, A. Zuniga, J. Pavlovic, M. A. Billeter, and R. Cattaneo Roles of Macrophages in Measles Virus Infection of Genetically Modified Mice J. Virol., April 1, 2001; 75(7): 3343 - 3351. [Abstract] [Full Text]

				A. M. A. Imam, G. P. Patrinos, M. de Krom, S. Bottardi, R. J. Janssens, E. Katsantoni, A. W. K. Wai, D. J. Sherratt, and F. G. Grosveld Modification of human {beta}-globin locus PAC clones by homologous recombination in Escherichia coli Nucleic Acids Res., June 15, 2000; 28(12): e65 - e65. [Abstract] [Full Text] [PDF]